Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
This study has been withdrawn prior to enrollment.
(Site decided not to open this study)
Sponsor:
British Columbia Cancer Agency
Information provided by:
British Columbia Cancer Agency
ClinicalTrials.gov Identifier:
NCT00627835
First received: February 14, 2008
Last updated: November 3, 2010
Last verified: November 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |